The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis

被引：0
|
作者：
Fa Mee Doh
Tae-Ik Chang
Hyang Mo Koo
Mi Jung Lee
Dong Ho Shin
Chan Ho Kim
Kwang Il Ko
Hyung Jung Oh
Tae-Hyun Yoo
Shin-Wook Kang
Dae-Suk Han
Seung Hyeok Han
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] NHIC Ilsan Hospital,Division of Nephrology
[3] Yonsei University,Brain Korea 21 for Medical Science, Severance Biomedical Science Institute
来源：
Cardiovascular Drugs and Therapy | 2012年 / 26卷
关键词：
HMG-CoA reductase inhibitor; Insulin resistance; Peritoneal dialysis; Adipokine; Chronic inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 509
页数：8
相关论文
共 50 条
  • [41] HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 183 : 295 - 310
  • [42] HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    HASUMI, K
    NATURAL PRODUCT REPORTS, 1993, 10 (06) : 541 - 550
  • [43] HMG-CoA reductase inhibitors
    Illingworth, DR
    Tobert, JA
    ADVANCES IN PROTEIN CHEMISTRY, VOL 56: DRUG DISCOVERY AND DESIGN, 2001, 56 : 77 - 114
  • [44] HMG-COA REDUCTASE INHIBITORS
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1988, 40 (06): : 477 - 477
  • [45] HMG-COA REDUCTASE INHIBITORS
    GRUNDY, SM
    JOURNAL OF INTERNAL MEDICINE, 1990, 228 (03) : 201 - 205
  • [46] HMG-CoA reductase inhibitors
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (01) : 77 - 78
  • [47] Effect of Eicosapentaic Acid and HMG-CoA Reductase Inhibitor on Chronic Heart Failure
    Node, Koichi
    Kotooka, Norihiko
    Oyama, Jun-Ichi
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S139 - S139
  • [48] Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia
    BakkerArkema, RG
    Davidson, MH
    Goldstein, RJ
    Davignon, J
    Isaacsohn, JL
    Weiss, SR
    Keilson, LM
    Brown, WV
    Miller, VT
    Shurzinske, LJ
    Black, DM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02): : 128 - 133
  • [49] No effect of age or gender on the pharmacokinetics of rosuvastatin: A new HMG-CoA reductase inhibitor
    Martin, PD
    Dane, AL
    Nwose, OM
    Schneck, DW
    Warwick, MJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (10): : 1116 - 1121
  • [50] Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia
    BakkerArkema, RG
    Davidson, MH
    Goldstein, RJ
    Davignon, J
    Isaacsohn, JL
    Weiss, SR
    Keilson, LM
    Brown, WV
    Miller, VT
    Shurzinske, LJ
    Black, DM
    PERFUSION, 1996, 9 (05): : 163 - &
12345